Mechanically, FBXO22 promotes NSCLC cell growth through inhibiting LKB1/AMPK/mTOR signaling pathway, which reinforces the oncogene function of FBXO22 in lung cancer. This evidence concerns the gene MTOR and non-small cell lung carcinoma.